CompletedPhase 1

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

United States21 participantsStarted 2011-01

Plain-language summary

Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel. Assessment of safety after repeated skin application.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of moderate papulopustular rosacea * free of any clinically significant disease Exclusion Criteria: * body weight less than 50 or more than 130 kg * clinically significant disease which could interfere with the study

What they're measuring

Baseline corrected area under the curve (AUC)

Timeframe: 12 hours

Trial details

NCT IDNCT01257919

SponsorLEO Pharma

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-03

View on ClinicalTrials.gov More Papulopustular Rosacea trials